Lansen Pharmaceutical Holdings Limited Appoints Chen Li as Executive Managing Director, Member of the Executive Committee and the Chief Executive Officer with Effect from 1 March 2018

Lansen Pharmaceutical Holdings Limited announced that Mr. Chen Li will be appointed as the Executive Managing Director of Lansen, a member of the Executive Committee and the Chief Executive Officer of the Lansen group with effect from 1 March 2018. Mr. Chen Li, age 56, has over 25 years of experience in the pharmaceutical industry. Prior to joining the Lansen group, Mr. Chen has been General Manager in Alfa Wassermann China since July 2014.

Mr. Chen worked for a number of internationally renowned pharmaceutical companies in the past. He was previously General Manager of China in Abbot from June 2009 to November 2012 and Assistant Vice President in Wyeth Pharmaceuticals Shanghai from 2004 to June 2009.